EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Matrix Remodeling Enzymes as Potential Fluid Biomarkers of Neurodegeneration in Alzheimer’s Disease

Jelena Bašić iD, Vuk Milošević iD, Branka Djordjević, Vladana Stojiljković iD, Milica Živanović iD, Nikola Stefanović, Aleksandra Aracki Trenkić, Dragan Stojanov, Tatjana Jevtović Stoimenov, Ivana Stojanović

International Journal of Molecular Sciences · 24.05.2024 · 25 (11) · 5703

DOI: 10.3390/ijms25115703 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 24.05.2024. Verfasst von Jelena Bašić und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Faculty of Medicine, University of Niš, 18000 Niš, Serbia. Hauptthemen laut MEDLINE: Alzheimer Disease, Biomarkers, Tissue Inhibitor of Metalloproteinase-1, Matrix Metalloproteinase 9. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science, Technological Development and Innovation of the Republic of Serbia, Faculty of Medicine University of Niš, Serbia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study investigated the diagnostic accuracy of plasma biomarkers—specifically, matrix metalloproteinase (MMP-9), tissue inhibitor of metalloproteinase (TIMP-1), CD147, and the MMP-/TIMP-1 ratio in patients with Alzheimer’s disease (AD) dementia. The research cohort comprised patients diagnosed with probable AD dementia and a control group of cognitively unimpaired (CU) individuals. Neuroradiological assessments included brain magnetic resonance imaging (MRI) following dementia protocols, with subsequent volumetric analysis. Additionally, cerebrospinal fluid (CSF) AD biomarkers were classified using the A/T/N system, and apolipoprotein E (APOE) ε4 carrier status was determined. Findings revealed elevated plasma levels of MMP-9 and TIMP-1 in AD dementia patients compared to CU individuals. Receiver operating characteristic (ROC) curve analysis demonstrated significant differences in the areas under the curve (AUC) for MMP-9 (p < 0.001) and TIMP-1 (p < 0.001). Notably, plasma TIMP-1 levels were significantly lower in APOE ε4+ patients than in APOE ε4− patients (p = 0.041). Furthermore, APOE ε4+ patients exhibited reduced hippocampal volume, particularly in total, right, and left hippocampal measurements. TIMP-1 levels exhibited a positive correlation, while the MMP-9/TIMP-1 ratio showed a negative correlation with hippocampal volume parameters. This study sheds light on the potential use of TIMP-1 as a diagnostic marker and its association with hippocampal changes in AD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseBiomarkersTissue Inhibitor of Metalloproteinase-1Matrix Metalloproteinase 9Magnetic Resonance ImagingHumansMaleFemaleAgedMiddle AgedApolipoprotein E4HippocampusAged, 80 and overROC Curve

Stichwörter der Autor:innen

APOE ε4Alzheimer’s diseasehippocampal volumematrix metalloproteinase-9tissue inhibitor of metalloproteinase-1

Substanzen

BiomarkersTissue Inhibitor of Metalloproteinase-1Matrix Metalloproteinase 9TIMP1 protein, humanMMP9 protein, humanApolipoprotein E4

Autor:innen und Institutionen

  • Department of Biochemistry, Faculty of Medicine, University of Niš, 18000 Niš, Serbia.
  • Faculty of Medicine, University of Niš, 18000 Niš, Serbia.
  • Clinic of Neurology, University Clinical Center Niš, 18000 Niš, Serbia.
  • Center for Radiology, University Clinical Center Niš, 18000 Niš, Serbia.
  • Department of Pharmacy, Faculty of Medicine, University of Niš, 18000 Niš, Serbia.

ORCID-Profile: Jelena Bašić, Vuk Milošević, Vladana Stojiljković, Milica Živanović

Förderung

  • Ministry of Science, Technological Development and Innovation of the Republic of Serbia
  • Faculty of Medicine University of Niš, Serbia

Zitieren

APA

Bašić, J., Milošević, V., Djordjević, B., Stojiljković, V., Živanović, M., Stefanović, N., Aracki Trenkić, A., Stojanov, D., Jevtović Stoimenov, T., & Stojanović, I. (2024). Matrix Remodeling Enzymes as Potential Fluid Biomarkers of Neurodegeneration in Alzheimer’s Disease. International Journal of Molecular Sciences, 25(11), 5703. https://doi.org/10.3390/ijms25115703

Vancouver

Bašić J, Milošević V, Djordjević B, Stojiljković V, Živanović M, Stefanović N, et al. Matrix Remodeling Enzymes as Potential Fluid Biomarkers of Neurodegeneration in Alzheimer’s Disease. International Journal of Molecular Sciences. 2024;25(11):5703. doi:10.3390/ijms25115703

BibTeX
@article{Bai2024,
  author = {Bašić, Jelena and Milošević, Vuk and Djordjević, Branka and Stojiljković, Vladana and Živanović, Milica and Stefanović, Nikola and Aracki Trenkić, Aleksandra and Stojanov, Dragan and Jevtović Stoimenov, Tatjana and Stojanović, Ivana},
  title = {Matrix Remodeling Enzymes as Potential Fluid Biomarkers of Neurodegeneration in Alzheimer’s Disease},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {11},
  pages = {5703},
  doi = {10.3390/ijms25115703}
}
Kostenlos starten →